Arvinas (ARVN) Enterprise Value (QoQ) (2018 - 2026)
Arvinas (ARVN) Enterprise Value (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Arvinas | 530.56 Mn | -84.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.29% |
| Dec 31, 2025 | 12.98% |
| Sep 30, 2025 | 8.55% |
| Jun 30, 2025 | 9.76% |
| Mar 31, 2025 | 8.19% |
| Dec 31, 2024 | -1,119.95% |
| Sep 30, 2024 | 46.85% |
| Jun 30, 2024 | 86.29% |
| Mar 31, 2024 | -268.63% |
| Dec 31, 2023 | -166.11% |
| Sep 30, 2023 | -24.04% |
| Jun 30, 2023 | 29.18% |
| Mar 31, 2023 | -56.34% |
| Dec 31, 2022 | 37.15% |
| Sep 30, 2022 | -41.35% |
| Jun 30, 2022 | -46.26% |
| Mar 31, 2022 | 40.78% |
| Dec 31, 2021 | 92.70% |
| Sep 30, 2021 | -2,801.71% |
| Jun 30, 2021 | 91.83% |